[JAMA医学新闻]:免疫功能抑制人群新冠病毒感染指导意见更新已关闭评论
Medical News in Brief
February 8, 2023
Updated COVID-19 Guidance for People Who Are Immunocompromised
Emily Harris
JAMA. Published online February 8, 2023. doi:10.1001/jama.2023.1176
In late January, the US Food and Drug Administration announced that Evusheld (the combined monoclonal antibodies tixagevimab and cilgavimab) is not currently authorized for emergency use because it’s likely ineffective against more than 90% o...
阅读全文
[JAMA临床指南精要]:心衰的治疗已关闭评论
JAMA Clinical Guidelines Synopsis
September 15, 2022
Management of Heart Failure
Mark N. Belkin, Adam S. Cifu, Sean Pinney
JAMA. 2022;328(13):1346-1347. doi:10.1001/jama.2022.16667
Guideline title 2022 American College of Cardiology (ACC)/American Heart Association AHA)/Heart Failure Society of America (HFSA) Guidelines for the Management of Heart Failure
Release date April 1, 2022
Prior versions 2017 ACC/AHA/HFSA Focused Update o...
阅读全文
[JAMA临床指南精要]:心衰的治疗已关闭评论
JAMA Clinical Guidelines Synopsis
September 15, 2022
Management of Heart Failure
Mark N. Belkin, Adam S. Cifu, Sean Pinney
JAMA. Published online September 15, 2022. doi:10.1001/jama.2022.16667
Guideline title 2022 American College of Cardiology (ACC)/American Heart Association AHA)/Heart Failure Society of America (HFSA) Guidelines for the Management of Heart Failure
Release date April 1, 2022
Prior versions 2017 ACC/AH...
阅读全文
0℃
JAMA Clinical Guidelines Synopsis
August 8, 2022
Treatment of Clostridioides difficile Infection
Kanika Sehgal, Adam S. Cifu, Sahil Khanna
JAMA. Published online August 8, 2022. doi:10.1001/jama.2022.12251
Guideline title ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections
Release date May 18, 2021
Prior version 2013
Developer American College o...
阅读全文
0℃
US Preventive Services Task Force
Recommendation Statement
August 23/30, 2022
Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force
JAMA. 2022;328(8):746-753. doi:10.1001/jama.2022.13044
Abstract
Importance Cardiovascular disease (CVD) is the leading cause of morbidity and death in the US and is the cause of more...
阅读全文
0℃
PULMONARY VASCULAR: GUIDELINES AND CONSENSUS STATEMENTS| VOLUME 162, ISSUE 1, P213-225, JULY 01, 2022
Thromboprophylaxis in Patients With COVID-19: A Brief Update to the CHEST Guideline and Expert Panel Report
Lisa K. Moores, Tobias Tritschler, Shari Brosnahan, et al
Chest 2022; 162: 213-225 Published:February 12, 2022
DOI:https://doi.org/10.1016/j.chest.2022.02.006
Background
Patients hospitalized with COVID-19 often exhibit markers of a ...
阅读全文
0℃
Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase–Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections
Pranita D. Tamma, Samuel L. Aitken, Robert A. Bonomo, et al
Clinical Infectious Diseases 2022; 74(12): 2089-2114
AMPC Β-LACTAMASE–PRODUCING ENTEROBACTERALES
Question 1: Which Enterobacterales Should Be Considered at Moderate to High Risk for Clinically Signific...
阅读全文
0℃
US Preventive Services Task Force
Recommendation Statement
June 21, 2022
Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force
JAMA. 2022;327(23):2326-2333. doi:10.1001/jama.2022.8970
Abstract
Importance According to National Health and Nutrition Examination Survey data, 52% of surveyed US a...
阅读全文
0℃
Research Special Paper
Visualising harms in publications of randomised controlled trials: consensus and recommendations
Rachel Phillips, Suzie Cro, Graham Wheeler, et al
BMJ 2022; 377 doi: https://doi.org/10.1136/bmj-2021-068983 (Published 16 May 2022)Cite this as: BMJ 2022;377:e068983
Abstract
Objective To improve communication of harm in publications of randomised controlled trials via the development of recommendations for visually presen...
阅读全文
0℃
JAMA Clinical Guidelines Synopsis May 16, 2022
Antithrombotic Therapy for Venous Thromboembolism
Christopher D. Jackson, Adam S. Cifu, Desirée C. Burroughs-Ray
JAMA. Published online May 16, 2022. doi:10.1001/jama.2022.7325
Guideline title Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report
Developer and funding source American College of Chest Physicians
Release date August 2...
阅读全文